Lehman & Derafelo Financial Resources LLC Editas Medicine, Inc. Transaction History

Lehman & Derafelo Financial Resources LLC

  • $337 Million
  • Q4 2022

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

Apr 21, 2021
SELL
$39.71 - $90.58 $180,680 - $412,139
-4,550 Closed
0 $0
Q4 2020

Jan 20, 2021
BUY
$27.07 - $84.35 $37,898 - $118,089
1,400 Added 44.44%
4,550 $319,000
Q3 2020

Nov 06, 2020
BUY
$28.06 - $37.16 $88,389 - $117,053
3,150 New
3,150 $88,000

Others Institutions Holding EDIT

# of Institutions
248
Shares Held
57M
Call Options Held
410K
Put Options Held
394K
View Full List

About Editas Medicine, Inc.

EDIT Quotes by TradingView
  • Ticker EDIT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,737,200
  • Market Cap $83.2M
  • Description
  • Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...
More about EDIT
Track This Portfolio

Track Lehman & Derafelo Financial Resources LLC Portfolio

Follow Lehman & Derafelo Financial Resources LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lehman & Derafelo Financial Resources LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lehman & Derafelo Financial Resources LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email